Skip to main content
Simcere Pharmaceutical Group Limited logo

Simcere Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · S2P ISIN · HK0000658531 HKEX Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2024-05-24 Transaction in Own Shar…
Country CN China
Listing HKEX S2P

About Simcere Pharmaceutical Group Limited

https://www.simcere.com/en/

Simcere Pharmaceutical Group Limited is an R&D-driven pharmaceutical company specializing in the discovery, development, and commercialization of innovative and branded generic prescription drugs. The company strategically focuses on core therapeutic areas, including neuroscience, anti-oncology, and inflammatory diseases. Simcere emphasizes synergistic innovation, evidenced by its development and launch of multiple Category I innovative pharmaceuticals and its strategic collaborations with global partners to advance novel treatments. These partnerships aim to address significant unmet medical needs and expand the company's portfolio across specialized disease areas.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Simcere Pharmaceutical Group Limited. It details multiple repurchases of shares over various dates, including quantities and prices, and confirms compliance with listing rules. The document is a regulatory disclosure about share repurchases, not a financial report or earnings release. It fits the description of a 'Transaction in Own Shares' filing, which reports the company's buyback activities. The document length is about 14,410 characters, containing detailed transactional data, not just an announcement or certification. Therefore, the appropriate classification is POS (Transaction in Own Shares).
2024-05-24 English
NOTIFICATION LETTER AND REPLY FORM TO NON-REGISTERED HOLDERS: NOTICE OF PUBLICATION OF CIRCULAR AND NOTICE OF ANNUAL GENERAL MEETING
Report Publication Announcement Classification · 95% confidence The document is a notification letter addressed to non-registered shareholders regarding the publication of a circular and notice of the Annual General Meeting (AGM). It informs shareholders about the availability of corporate communications electronically and provides instructions on how to receive printed copies. The document does not contain any financial data, management discussion, voting results, or detailed report content. It is essentially an announcement about the publication and dissemination of corporate communications, including the AGM notice and circular, rather than the reports themselves. The length is under 10,000 characters and the content is primarily a notification and request form for shareholders to opt for printed communications. Therefore, according to the "Menu vs Meal" rule, this document is best classified as a Report Publication Announcement (RPA).
2024-05-23 English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS: NOTICE OF PUBLICATION OF CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM
Report Publication Announcement Classification · 95% confidence The document is a notification letter to shareholders regarding the publication of a circular, notice of annual general meeting (AGM), and proxy form. It informs shareholders about the availability of these corporate communications electronically and solicits their consent or preference for receiving future communications electronically or in printed form. The document does not contain any financial data, management discussion, or detailed report content. It is essentially an announcement about the publication and distribution method of corporate communications, including the AGM notice and proxy form, rather than the AGM materials themselves or any financial report. The document length is about 12,701 characters, which is relatively short and consistent with an announcement letter rather than a full report. Therefore, according to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA) type document, notifying shareholders of the availability of the circular and AGM notice on the company website and soliciting their preferences for receiving future communications.
2024-05-23 English
PROXY FORM FOR ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy form for the Annual General Meeting (AGM) of Simcere Pharmaceutical Group Limited. It includes instructions for shareholders to appoint proxies to vote on resolutions at the AGM, such as adopting financial statements, declaring dividends, re-electing directors, and granting mandates. The content is procedural and related to voting at the AGM, not the actual AGM presentation materials or the full annual report. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length (7,135 characters) and content confirm it is not a brief announcement or a full report but a detailed proxy form for shareholder voting.
2024-05-23 English
(I) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND TO REPURCHASE SHARES&#x3b; (II) PROPOSED RE-ELECTION OF RETIRING DIRECTORS&#x3b; (III) PROPOSED DECLARATION AND PAYMENT OF FINAL DIVIDEND&#x3b; A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Simcere Pharmaceutical Group Limited dated May 24, 2024, containing detailed information about the upcoming Annual General Meeting (AGM) scheduled for June 14, 2024. It includes proposed resolutions such as granting general mandates to issue and repurchase shares, re-election of retiring directors, declaration and payment of final dividend, and the notice of the AGM itself. The document also contains explanatory statements and biographical details of directors proposed for re-election, as well as proxy form instructions. The content is typical of a proxy circular or meeting circular sent to shareholders to inform them about the AGM agenda and related proposals. It is not the AGM presentation materials, nor is it the actual voting results or minutes. It is not a financial report or earnings release. Given the detailed nature of the circular and the inclusion of the AGM notice and proxy form, this document fits best under the category of Proxy Solicitation & Information Statement (PSI).
2024-05-23 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the Annual General Meeting (AGM) for Simcere Pharmaceutical Group Limited. It includes details about the date, time, and location of the AGM, the agenda items such as adoption of audited financial statements, dividend declaration, re-election of directors, appointment of auditors, and approval of share issuance and repurchase mandates. The document is a formal notice inviting shareholders to attend and vote at the AGM, not the actual report or minutes of the meeting. It does not contain financial statements or detailed financial analysis but rather the agenda and procedural information for the AGM. Therefore, it fits the category of AGM Information (AGM-R).
2024-05-23 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.